EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rise of the RNA machines – self-amplification in mRNA vaccine design

Jerome D G Comes, Gorben P Pijlman, Tessy A H Hick

Trends in Biotechnology · 2023-11 · 41 (11) · 1417-1429

DOI: 10.1016/j.tibtech.2023.05.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2023-11. Verfasst von Jerome D G Comes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wageningen University and Research, Laboratory of Virology, Droevendaalsesteeg 1, 6708PB, Wageningen, The Netherlands. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, SARS-CoV-2, RNA, Messenger. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technology Foundation STW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA vaccines have won the race for early COVID-19 vaccine approval, yet improvements are necessary to retain this leading role in combating infectious diseases. A next generation of self-amplifying mRNAs, also known as replicons, form an ideal vaccine platform. Replicons induce potent humoral and cellular responses with few adverse effects upon a minimal, single-dose immunization. Delivery of replicons is achieved with virus-like replicon particles (VRPs), or in nonviral vehicles such as liposomes or lipid nanoparticles. Here, we discuss innovative advances, including multivalent, mucosal, and therapeutic replicon vaccines, and highlight novelties in replicon design. As soon as essential safety evaluations have been resolved, this promising vaccine concept can transform into a widely applied clinical platform technology taking center stage in pandemic preparedness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19SARS-CoV-2RNA, MessengerVaccines, SyntheticmRNA VaccinesHumansReplicon

Stichwörter der Autor:innen

lipid nanoparticlesmRNAplatform technologyrepliconself-amplifying RNAvaccines

Substanzen

COVID-19 VaccinesRNA, MessengerVaccines, SyntheticmRNA Vaccines

Autor:innen und Institutionen

  • Wageningen University and Research, Laboratory of Virology, Droevendaalsesteeg 1, 6708PB, Wageningen, The Netherlands.
  • Wageningen University and Research, Laboratory of Virology, Droevendaalsesteeg 1, 6708PB, Wageningen, The Netherlands. Electronic address: gorben.pijlman@wur.nl.

Förderung

  • Technology Foundation STW

Zitieren

APA

Comes, J. D. G., Pijlman, G. P., & Hick, T. A. H. (2023). Rise of the RNA machines – self-amplification in mRNA vaccine design. Trends in Biotechnology, 41(11), 1417-1429. https://doi.org/10.1016/j.tibtech.2023.05.007

Vancouver

Comes JDG, Pijlman GP, Hick TAH. Rise of the RNA machines – self-amplification in mRNA vaccine design. Trends in Biotechnology. 2023;41(11):1417-1429. doi:10.1016/j.tibtech.2023.05.007

BibTeX
@article{Comes2023,
  author = {Comes, Jerome D G and Pijlman, Gorben P and Hick, Tessy A H},
  title = {Rise of the RNA machines – self-amplification in mRNA vaccine design},
  journal = {Trends in Biotechnology},
  year = {2023},
  volume = {41},
  number = {11},
  pages = {1417--1429},
  doi = {10.1016/j.tibtech.2023.05.007}
}
Kostenlos starten →